Crucell About
Crucell Crucell's development pipeline is based on a number
of criteria: (1) there is an unmet medical need, (2) our PER.C6® technology adds
value, (3) there are predictable preclinical models, (4) they can anticipate a
potentially short time to market and (5) there is a modest cost per program. Crucell's
current vaccine candidates against West Nile virus, Influenza,
Malaria
and Ebola,
are in various stages of pre-clinical development. More
on Crucell
Crucell
is a biotechnology company focused on developing products that prevent and treat
infectious diseases. They are leveraging their unique PER.C6® technology to develop
and produce novel vaccines and antibodies that address important unmet health
needs.